The contrasting distribution of FlnA in the nucleus or in the cytoplasm is consistent with clinical data in which immunohistochemistry analysis demonstrated that cytoplasmic localization of FlnA is highly correlated with metastases of prostate cancer (23). The gene discussed is FLNA; the disease is Familial prostate cancer.